 risk factors for rebleeding and the timing of these disastrous events; determination of the safety and effectiveness of antifibrinolytic agents and development of an administration schedule which optimizes the actions in preventing rebleeding and minimizes ischemic neurological complications; documentation of the diagnostic and prognostic value of CT scanning in subarachnoid
risk factors for rebleeding and the timing of these disastrous events; decision of the condom and effectiveness of antifibrinolytic agents and development of an government schedule which optimizes the action in preventing rebleeding and minimizes ischemic neurological complications; software documentation of the diagnostic and predictive value of CT scanning in subarachnoid
 ridk factors for rebleedinn and the timing of theve diszstrous dvents; determination of the dadety qnd effectiveness of avtifibrinllytic atentw and development on an zfminnsvration schedulg which optikizes the actimnr nn preventing rebleeding and minimizqs ischrmlc neurologicaj cok[liczniins; documentation of the diaghostic end prognostic falue of CT scanning in suharafhnoid
risk factors for rebleeding and the timing disastrous determination of safety and effectiveness of administration schedule which the actions in rebleeding and minimizes ischemic neurological complications; of the diagnostic and prognostic value of CT scanning in subarachnoid
 risk factors for rebleeding aNd the timinG of thEse DisAsTrouS eveNts; determinatiON of tHe safety and effectiveneSs of aNtIFibrINoLytic Agents aND dEVEloPmEnT of An ADmInistRatIon scheDule which oPtiMiZes the actionS In Preventing RebLeeding and miNimIzes isChEmiC NeuroLogIcal cOmplicATions; dOcumentatIoN Of the dIAgnostiC ANd ProgNostic value of CT scANnINg in subarachnoId
 risk factors for rebleedi ng and the  timi ngofth esedisa strous events; dete rmination of the safet y and  e f fect i ve nessof anti f ib r i nol yt ic  ag en t sand d eve lopment  of an adm ini st ration sched u le  which opt imi zes the acti ons  in pr ev ent i ng re ble eding  and m i nimize s ischemi cn eurolo g ical co m p li cati ons; documentatio n  o f  the diagnosti c andpr o gn o s tic  va lue of CTsc annin g  in sub a ra c h n oid 
 risk_factors for_rebleeding and the timing_of these_disastrous_events; determination_of_the safety and_effectiveness of antifibrinolytic_agents and development of_an administration schedule_which_optimizes the actions in preventing rebleeding and minimizes ischemic neurological complications; documentation of the_diagnostic_and prognostic_value_of_CT scanning in subarachnoid